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tis, acini are gradually destroyed and substituted by fi-
brotic tissue. The histopathologic changes consist mainly 
of irregularly distributed fibrosis, reduced number of aci-
ni and islets of Langerhans, and variable changes and ob-
struction of pancreatic ducts of all sizes. The duct system 
may show strictures, intraductal plugs and calcifications. 
The irreversible structural changes can be visualized 
years before any clinical manifestation of chronic pan-
creatitis is present. The principal clinical events in the 
course of chronic pancreatitis are episodes of acute pan-
creatitis, with acute inflammation superimposed on an 
irreversibly damaged organ  [10–15] .
 Pain 
 Pain is the main symptom of chronic pancreatitis  [1, 
3, 16] . The events that trigger pain in chronic pancreatitis 
are poorly understood. Pain is described as a constant 
epigastric pain, often radiating to the back. Sometimes 
pain is associated with nausea and vomiting. At the be-
ginning of the disease, patients report very little pain, 
especially in the initial stages of chronic, alcoholic pan-
creatitis. Over time, pain episodes are more frequent and 
of longer duration; finally, constant pain can develop. 
Food intake increases or provokes pain; this can lead to 
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 Abstract 
 The diagnosis of chronic pancreatitis is based on a typical 
history with recurrent flares of acute inflammation, imaging 
procedures and some laboratory tests.  Using imaging pro-
cedures (abdominal ultrasound, computed tomography or 
magnetic resonance imaging), a diagnosis can only be made 
when alterations in size (enlargement or atrophy) or shape 
of the pancreas or changes in intrapancreatic structure (di-
lation, obstruction of ducts), calcifications, or changes in 
peripancreatic organs have occurred. Tests of exocrine pan-
creatic function are not essential for making a diagnosis of 
chronic pancreatitis.  Copyright © 2010 S. Karger AG, Basel 
 Introduction 
 Chronic pancreatitis is a chronic inflammatory pro-
cess leading to irreversible destruction of exocrine and 
endocrine tissue and fibrosis  [1–9] . In chronic pancreati-
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weight loss and malnutrition as patients under these cir-
cumstances have a tendency to avoid regular meal in-
take. The principal symptoms and findings are listed in 
 table 1 . 
 Pancreatic Insufficiency 
 10–20% of pain-free patients with chronic pancreatitis 
suffer from exocrine and endocrine pancreatic insuffi-
ciency  [1, 17–19] . The classical combination of steator-
rhea, diabetes mellitus and pancreatic calcifications is 
found in less than one third of patients at the time of di-
agnosis. Weight loss is common during the course of the 
disease. Malabsorption is one of several important causes 
for it. As mentioned before, many patients limit their food 
intake because of pain during eating. Patients with severe 
exocrine pancreatic insufficiency are unable to adequate-
ly digest food (maldigestion). Fat hydrolysis is more af-
fected than protein or carbohydrate digestion, because 
lipase secretion decreases more rapidly than the secretion 
of proteolytic enzymes. Steatorrhea therefore precedes 
the development of protein malabsorption. When pa-
tients attempt to compensate for malabsorption by over-
eating, increased fat intake leads to increased gastrointes-
tinal symptoms such as bloating, abdominal cramps, flat-
ulence  [20] . In view of the intact absorptive capacity and 
enterohepatic circulation of bile salts, malabsorption of 
vitamins (A, D, E, K), calcium and iron is uncommon in 
patients with chronic pancreatitis (this is in contrast to 
patients with untreated celiac disease). About 40% of pa-
tients with severe exocrine pancreatic insufficiency have 
a vitamin B 12 malabsorption, but a clinically relevant 
 deficiency in vitamin B 12 or fat-soluble vitamins is rare
 [20, 21] .
 Glucose Intolerance and Diabetes Mellitus 
 Patients with chronic pancreatitis often develop glu-
cose intolerance, but overt diabetes mellitus is a late 
symptom during the course of the disease, typically 20 
years after the beginning of the disease. An endocrine 
insufficiency develops with the progression of the de-
struction of the organ in about 60% of patients  [9] . Most 
of them develop an insulin-dependent diabetes mellitus, 
which can be aggravated by a decrease in glucagon secre-
tion. The concomitant maldigestion and the continuing 
alcohol consumption increase the risk of an islet cell in-
sufficiency with the potential risk of spontaneous hypo-
glycemia. The treatment of diabetes mellitus in chronic 
pancreatitis can be difficult, but severe diabetic ketoaci-
dosis is rare.
 Diagnosis 
 The diagnosis of chronic pancreatitis is in general not 
difficult: a typical medical history with recurrent attacks 
of acute pancreatitis, an imaging procedure (ultrasound, 
computed tomography – CT scan, or endoscopic retro-
grade cholangiopancreatography – ERCP/magnetic reso-
nance cholangiopancreatography – MRCP) with typical 
radiologic features of chronic pancreatitis. Additionally, 
exocrine and endocrine pancreatic function tests can be 
performed in selected cases. Serum concentrations of 
pancreatic enzymes (amylase and lipase )  are increased 
during acute attacks, but they are normal in the intervals. 
In progressive disease state serum concentrations of pan-
creatic enzymes can be normal even during acute flares 
 [1, 14] . The absolute increase in amylase or lipase concen-
tration does not predict the outcome. An increase in al-
kaline phosphatase and/or   -glutamyl-transferase con-
centrations or in bilirubin in the interval without clinical 
evidence of an acute flare-up suggests a common bile 
duct obstruction. The intrapancreatic portion of the 
common bile duct is obstructed in 5–20% of persons with 
chronic pancreatitis, but not all of them require a thera-
peutic intervention  [22, 23] . Stenosis of the common bile 
duct and extrinsic compression of the duct system are 
possible causes of these findings.
 Imaging Procedures 
 In about 30% of patients with chronic pancreatitis, a 
plain abdominal radiograph reveals diffuse or focal pan-
creatic calcifications. Calcifications are primarily seen in 
patients with alcoholic or tropical pancreatitis, but they 
Table 1. T ypical symptoms and findings in chronic pancreatitis
Symptom/finding Prevalence, %
Pain 80–98
Weight loss 5–85
Diabetes mellitus 50–60
Steatorrhea 30–40
Icterus 20–25
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are less common in hereditary idiopathic pancreatitis. A 
typical example of pancreatic calcifications on a plain ab-
dominal radiograph is depicted in  figure 1 .
 Ultrasonography/CT Scan.  Ultrasonography and CT 
scan of the abdomen have markedly changed the eval-
uation of patients with chronic pancreatitis  [1, 14, 15] . 
Thanks to these techniques, focal and diffuse irregulari-
ties of the pancreas, dilation of the main pancreatic duct, 
or calcifications can be observed. CT has been shown to 
be superior to ultrasonography, for example in detecting 
pseudocysts. In the presence of overlying gas, ultrasonog-
raphy is insufficient for visualization of the entire pan-
creas. The sensitivity and specificity of abdominal ultra-
sound in detecting pathological changes of the organ is 
around 60–70 and 80–90%, respectively. CT has a supe-
rior sensitivity ( 1 90%) with a similar specificity.
 Endoscopic Ultrasonography.  The indications for en-
doscopic ultrasonography (EUS) at this stage are: early 
identification of chronic pancreatitis, differentiation of 
inflammatory processes from malignant developments, 
and fine needle aspirations for pathological assessment of 
suspected lesions  [24, 25] . EUS requires high skills and 
expertise, but can achieve high sensitivity ( 1 90%) with a 
similar specificity (with an especially high negative pre-
dictive value). As mentioned before, the method is depen-
dent on the skills and expertise of the investigator  [26] . 
EUS-guided fine needle aspiration has become an impor-
tant diagnostic procedure in the diagnosis of unclear 
masses of the pancreas  [27] .
 Endoscopic Retrograde Cholangiopancreatography. 
 ERCP is no longer essential in the diagnosis of chronic 
pancreatitis, but still has its place in the management and 
therapy of patients with pancreatic disease  [6, 28, 29] . The 
average normal diameters of the pancreatic duct are  ! 4, 
 ! 3 and  ! 2 mm in the head, the body and the tail of the 
pancreas, respectively. According to the Cambridge Clas-
sification,  ductal changes are described as possible (Cam-
bridge I), mild to moderate (Cambridge II) or severe 
(Cambridge III)  [1, 6, 30] . The correlation of these duct 
changes with CT is best in severe cases. In advanced 
chronic pancreatitis, the main pancreatic duct is dilated 
 [31] . A typical example is given in  figure 2 . ERCP permits 
the identification of potentially surgically correctable le-
sions (strictures, cysts). Complications of ERCP include 
triggering acute pancreatitis and cholangitis, especially 
in patients with preexisting obstructive jaundice  [29, 32] .
 Magnetic Resonance Cholangiopancreatography. 
 MRCP has been developed into an excellent imaging pro-
cedure which is able to document small structural chang-
es in the visceral organs of the abdomen including the 
liver, bile ducts and pancreas. Several randomized com-
parative investigations have shown that MRCP imaging 
is equal to ERCP for diagnosing ductal changes in the 
biliary tract and the pancreas  [33, 34] . MRCP is, however, 
 Fig. 1. Plain abdominal X-ray in a patient with chronic pancreati-
tis; typical calcifications. 
 Fig. 2. ERCP in a patient with chronic pancreatitis; typical ductal 
changes; the main pancreatic duct is dilated. 
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a noninvasive procedure without a risk for acute pancre-
atitis compared to diagnostic ERCP. MRCP has therefore 
become the imaging procedure of choice for diagnostic 
workup of duct abnormalities of the pancreas. The pro-
cedure can be improved by intravenous secretin, which 
acts as a natural contrast agent  [35, 36] .
 Functional Assessment of Exocrine Pancreatic 
Secretion 
 Exocrine pancreatic insufficiency is best quantified by 
stool fat analysis or by direct assessment of exocrine pan-
creatic secretion by duodenal intubation and quantifica-
tion of pancreatic bicarbonate and/or enzyme responses 
in response to hormonal stimulation. The procedures are 
cumbersome; more important pathological results can 
only be obtained in advanced stages of exocrine pancre-
atic insufficiency. At this stage of disease, the tests are 
only necessary in selected cases.
 Fat Malabsorption.  Steatorrhea can be visualized by 
microscopy using Sudan stain test or by quantitative stool 
fat analysis (sensitivity and specificity is only acceptable 
at advanced stages of exocrine pancreatic insufficiency, 
when the gland is destroyed by  1 80%). Quantitative stool 
fat analysis is the gold standard for diagnosing malab-
sorption. The procedure entails a 72-hour stool collection 
with a standardized 100 g fat diet per day. The normal fat 
excretion is  ! 7 g fat/24 h; patients with severe exocrine 
pancreatic insufficiency can have  1 30 g fat/24 h.
 Intubation Tests with Direct Assessment of Exocrine 
Pancreatic Secretion.  Direct stimulation of exocrine pan-
creatic secretion is the best method for assessment of pan-
creatic function. The exocrine pancreas is stimulated 
with secretin alone or in combination with cholecystoki-
nin  [37] . The secretin-stimulated function test is probably 
the most sensitive procedure for the assessment of the 
exocrine pancreatic function. Nevertheless, more than 
60% of the function has to be destroyed in order to pro-
duce a pathological test result. The test procedure is time-
consuming and unpleasant for the patient; furthermore, 
the procedure has been difficult to standardize. The se-
cretin-stimulated function test has lost its clinical impor-
tance and is only done at selected centers, mainly for re-
search purposes. A simplified test procedure has recently 
been published: the duodenal juice before and after secre-
tin stimulation is collected during a routine upper endos-
copy  [38, 39] . The accuracy of the endoscopic pancreatic 
function tests is similar to duodenal intubation. There 
were minimal differences in bicarbonate at each of the 
timed collections and at peak with an excellent correla-
tion in peak HCO 3 – and a high level of diagnostic agree-
ment between the tests. The method simplifies the test 
procedure, but its value remains limited.
 Indirect Assessment of Exocrine Pancreatic Function. 
 An alternative approach to the complicated intubation 
test for the assessment of exocrine pancreatic function is 
the measurement of stool elastase (sensitivity about 80%). 
The disadvantage of all indirect tests is that they have suf-
ficient sensitivity only in the presence of moderate to se-
vere pancreatic insufficiency. However, in many places, 
the assessment of stool elastase has established itself as 
the easiest test procedure  [40] . 
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